Skip to content
thestock.space

As of 6 Nov 2026, Jupiter Life Line Hospitals trades at 52.4× trailing earnings, above the industry P/E of 47.7×, and the shares are 15% below their 52-week high. It earns ROCE of 13% and ROE of 12%, and sales and net profit grew 19% and 39% a year over 3 years. Its dividend yield is 0.1%, and debt is 0.41× equity. It is a small-cap company with a market cap of ₹9,428 Cr, ranked 12th of 40 Medical Care Facilities companies by market cap; the shares fell 7.8% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹286.55
Day high
₹289.75
Day low
₹284.55
Prev. close
₹286.55
Volume
31.6K

Health check

2 good · 3 fair · 1 to check
  • ReturnsBehind

    −7.8% over a year, better than 2 of 7 peers.

  • Price tagIn line

    P/E 52.4 vs industry 47.7.

  • GrowthStrong

    Sales +18.8%, profit +38.6% a year over 3 years.

  • ProfitabilityAverage

    ROCE 13.3% vs peer median 11.9%.

  • Balance sheetFair

    Debt 0.41× equity, interest covered 10.5×, Piotroski 5 of 9.

  • Red flagsNone found

    No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹9,428 Cr, #12 of 40 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Sep 2026: sales ₹1,621 Cr · profit ₹186 Cr
Market cap
₹9,428 Cr
Small cap
P/E
52.4
Industry 47.7
Price to book
5.76
Peers 8.06
Dividend yield
0.07%
ROE
12.1%
Peers 12.8%
ROCE
13.3%
Peers 11.9%
Debt to equity
0.41
Debt ₹669 Cr
EPS (TTM)
₹5.49
Face value ₹2
OPM (TTM)
22.1%
Net margin 11.5%
Sales growth
+16.0%
Latest quarter vs a year ago
Profit growth
−1.9%
Latest quarter vs a year ago
Price to sales
5.82
EV/EBITDA 28.2

Strengths and risks

Strengths

  • Quarterly sales up 16.0% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Jupiter Life Line Hospitals

Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases,…

Headquarters
Mumbai
Employees
3,002
Sector
Healthcare
ISIN
INE682M01020
Website
jupiterhospital.com

Price range

52 weeks

₹233.40₹340.00

Today

₹284.55₹289.75
Avg volume (3M)
1.7 L
1-year return
minus 7.8%
From 52-week high
minus 15.4%

Analyst consensus

6 analysts
Strong buyMean target ₹322.17 plus 12.0%

Target range, with today’s price

Low ₹275.00High ₹350.00

Consensus from Yahoo Finance. Not a recommendation.

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
JLHLJupiter Life Line Hospitals287.60plus 0.37%9,42852.45.7613.3%12.1%22.1%18.8%38.6%0.07%minus 7.8%
Median of 7 peers–−0.65%62,09260.48.0611.9%12.8%18.5%16.5%14.7%0.21%4.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
394365388411456
301282299332350
92.283.489.279.3107
23.4%22.8%23.0%19.3%23.4%
11.39.19.110.610.5
7.87.5912.913.8
21.521.723.326.428.5
–−6.41.5––
74.256.967.650.675.1
22.6%25.3%25.6%25.8%24.9%
57.542.650.637.556.4
1.751.101.531.141.72

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+18.8%
Profit CAGR 3Y
+38.6%
EPS CAGR 3Y
+38.6%
ROE
12.1%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
8931,0701,3011,498
–+19.8%+21.7%+15.2%
6908299981,153
202241304345
22.7%22.5%23.3%23.0%
6.221.314.225.2
38.722.73.427.3
38.642.457.187.6
−2.6−1.43.45.1
129195261260
43.4%9.6%25.7%25.4%
72.9177193194
–+142.2%+9.4%+0.4%
2.225.695.895.92

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
56.565.665.665.6
3091,1031,2911,479
469–393584
151112186255
9861,2811,9362,383
7497901,1591,625
30.274.6186249
1921.80.10.1
136318600540
51.476.8−9.4−31
9861,2811,9362,383

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
117115267268
−104−246−497−442
17.5128297136
31.1−3.566.1−37.8
−77.2−85.3−328−502
39.929.2−60.8−234
−5.1−5.7−6.6−6.6

Shareholding pattern

Source: NSE filings

NSE hasn’t returned a shareholding pattern for this company. Institutions hold about 24.1% (Yahoo estimate).

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you